一、概述···················································································································· 1二、撰写格式和要求······································································ 1（一）中药、天然药物新药申请········································································· 11、申请临床研究··························································································11.1主要研究结果综述····················································································· 11.2分析与评价······················································································ 32、申请生产············································································································· 32.1主要研究结果综述··················································································· 32.2分析与评价································································································ 4（二）已有国家标准的中药、天然药物的申请········································· 51、主要研究结果综述··············································································· 52、分析与评价································································································ 6三、参考文献··································································································· 6四、著者··················································································································· 6